Global Retirement Partners’s Aerie Pharmaceuticals AERI Stock Holding History

Global Retirement Partners’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,661	Closed	-$19K	–	1985
2021 Q3	$19K	Hold	1,661	–	–	﹤0.01%	1232
2021 Q2	$27K	Sell	1,661 -5	-0.3%	-$86	﹤0.01%	1097
2021 Q1	$30K	Buy	1,666 +839	+101%	+$14.5K	﹤0.01%	981
2020 Q4	$11K	Hold	827	–	–	﹤0.01%	1251
2020 Q3	$10K	Hold	827	–	–	﹤0.01%	1156
2020 Q2	$12K	Buy	827 +191	+30%	+$2.83K	﹤0.01%	1074
2020 Q1	$9K	Buy	636 +36	+6%	+$683	﹤0.01%	1071
2019 Q4	$15K	Buy	600 +145	+32%	+$3K	﹤0.01%	1056
2019 Q3	$9K	Buy	+455	New	+$10.4K	﹤0.01%	1156

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Global Retirement Partners's AERI Position: Q4 2021 in Review

Global Retirement Partners sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 1,661 shares — an estimated $19K sold.

Global Retirement Partners first reported a position in AERI in Q3 2019 and held it in 9 quarters. The position peaked at $30K in Q1 2021. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

Global Retirement Partners reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Global Retirement Partners sold 1,661 Aerie Pharmaceuticals shares in Q4 2021, an estimated $19K.
Global Retirement Partners first reported a position in Aerie Pharmaceuticals in Q3 2019 and held it in 9 quarters.
Global Retirement Partners's Aerie Pharmaceuticals position peaked at $30K in Q1 2021.
129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on Global Retirement Partners's 13F filing for Q4 2021, filed 21 Jan 2022.